✦ LIBER ✦

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B

✍ Scribed by José Luis Soto; Carmen M Cabrera; Salvio Serrano; Miguel Ángel López-Nevot

Book ID: 115010694
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 437 KB
Volume: 5
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-5-36

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of the CDKN2A, CDKN2B and CDK4

Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds

✍ Flores, José F; Pollock, Pamela M; Walker, Graeme J; Glendening, J Michael; Lin, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 350 KB

A single nucleotide polymorphism in the

A single nucleotide polymorphism in the 3′untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare

✍ Rajiv Kumar; Johanna Smeds; Petra Berggren; Oddbjørn Straume; Barbro Lundh Rozel 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 142 KB 👁 2 views

Comprehensive analysis of CDKN2A (p16INK

Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma

✍ Laud, K 📂 Article 📅 2005 🏛 BMJ Publishing Group 🌐 English ⚖ 274 KB

Screening of germline mutations in the C

Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study

✍ Anton Platz; Johan Hansson; Ulrik Ringborg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 2 views

Germline mutations within the CDKN2A gene, coding for the cyclin-dependent kinase inhibitor p16, have been detected by screening in 8% of Swedish families with an inheritance of cutaneous melanoma (FMM) and dysplastic nevus syndrome (DNS). Contrastingly, the closely related gene CDKN2B had no diseas

Effect of CYP1A1 MSPI Polymorphism on th

Effect of CYP1A1 MSPI Polymorphism on the Relationship Between TP53 Mutation and CDKN2A Hypermethylation in Non-small Cell Lung Cancer

✍ Cong Tan; He-yun Xu; Chen-ye Zhang; Hu Zhang; Chun-mei Chen; Wei-min Zhang; Xiao 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 359 KB

The CDKN2A/CDKN2B/CDK4/CCND1 pathway is

The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis. An analysis of 104 tumors

✍ Caroline Louis-Brennetot; Jean-Michel Coindre; Céline Ferreira; Gaëlle Pérot; Ph 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

## Abstract The __MDM2__ and __CDK4__ genes are the main targets of chromosome 12 amplification in well‐differentiated and dedifferentiated liposarcomas. Nevertheless, around 10% of these tumors do not amplify __CDK4__. To find substitutive alterations of __CDK4__ amplification, we analyzed a large